GSK said on Friday a panel of the European Medicines Agency had backed the use of its respiratory syncytial virus (RSV) ...
The recommendation by the CHMP should now result in approval of Arexvy in the broader age range in February next year, and ...
In the third quarter, our revenue were $1 billion, driven by sales of our fully approved vaccines, Spikevax, mNEXSPIKE, ...
Everyday Health on MSN
RSV could raise the risk of heart attack and stroke
In a new study, adults 45 and up who got this seasonal virus had a higher risk of major heart issues, especially in the first ...
Last month marked a major turning point as Google launched Gemini 3 [1], proving that new AI models can now outperform humans on critical tasks. At the same time, global regulators accelerated the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback